Wikidata

(Q40821842)

English

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM

scientific article published on July 2015

In more languages

Statements

title
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
26089047
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26089047%20AND%20SRC:MED&resulttype=core&format=json
retrieved
17 February 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40821842&oldid=1538378088"